跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rimactazid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rimactazid
Approved
STANDARD
Rimactazid
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e3284e1ce0e767ea
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
e3284e1ce0e767ea
Drug Approval Philippines Name
Rimactazid
Product Name
Rimactazid
Registration Number
DRP-5098
Brand Name
Rimactazid
Generic Name
Rifampicin + Isoniazid
Dosage Form
Tablet
Dosage Strength
300 mg/150 mg
Manufacturer
Interphil Laboratories, Inc.
Trader
Sandoz Philippines Corporation
Issuance Date
29 July 2020
Expiry Date
29 September 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e3284e1ce0e767ea
Type
Standard
Back to Philippines FDA Approvals